EventsFree Learning Tickets And BusinessCann Discounts on Premium Tickets...

Free Learning Tickets And BusinessCann Discounts on Premium Tickets For This Year’s GCI Europe Summit


THE annual GCI Europe Summit, which is taking place on-line this year, offers the opportunity to connect with some of the industry’s global thought-leaders.

Joseph Model, Head of Partnerships at Global Cannabis Intelligence (GCI) told BusinessCann this year’s summit gives virtual attendees the opportunity to ‘create a bespoke experience – across its curated multi-topic agenda – by participating in talks and networking with leaders most relevant to their working life’.

This year’s event is also different in the sense it is making a significant proportion of Learning Tickets available for free.

Mr Model continued: “Our unique format is centred around collaboration, bringing together leading, innovative organisations – from research, medicine, business and policy – to exchange ideas, partner and do business.

“With the cannabis industry increasingly prominent we want to use this year’s virtual platform as an opportunity for those seeking industry education to learn more – at no cost – from cannabis’ global thought leaders.

“Our free learning tickets are ideal for doctors, researchers, policy makers, patients and retailers interested in learning more from the experts at the Summit.”

The online event takes place from November 11 to 12 and features seven key themed areas:

Research & Applied Science
Medicine, Treatment & Patients
Regulations & European Canna Countries
Consumer Brands & International Retail
Finance & Investment
Cultivation, Ops & Tech

Those wanting to apply for a complimentary Learning Ticket can do so here

As part of our media partnership with GCI Europe Virtual Summit, BusinessCann readers can use this special discount code – BIZCAN15 – to redeem a 15% discount for Premium Tickets at the GCI Summit click here.

For further information on GCI Europe Virtual Summit click here.

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

MGC Pharmaceuticals Releases Update On CimetrA Clinical Trial Progress In USA

MGC Pharmaceuticals Ltd (ASX, LSE: MXC, ‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development...

European Cannabis Stocks Review: Akanda’s ‘Concerned Shareholders’ Oust All Directors Except CEO To Prevent ‘Potentially Irreparable Harm’ – More From Goodbody Health & Chill...

It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making...

Analysis Shows UK Market Could Grow To Over £1bn By 2026 As London Prepares To Host Europe’s Leading Cannabis Conference

ANALYSIS shows UK market could grow to over £1bn by 2026 as London prepares to host Europe’s leading cannabis...

Medical Cannabis Could Be Available In Spain By The End Of The Year

SPAIN could now see the regulation and distribution of medical cannabis rolled out before the end of the year...

New UK Company Heralds Its ‘Unique’ Medical Cannabis Delivery Mechanism

CANNABIS extraction and formulations specialist 113 Botanicals is in the process of securing Good manufacturing Practice (GMP) compliance for...

German Cannabis Bill By Year End With Adult-Use Launch Likely In Early 2024

GERMANY’s draft cannabis law should be ready by the end of the year with the launch of its adult-use...

Must read

You might also likeRELATED
Recommended to you